Clinical Trial Update: Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects [Phase 4]

View source ↗

Summary

Phase 4 implementation study evaluating treatment optimization recommendations for relapsing-remitting multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: EMD Serono | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: WITHDRAWN